| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Team Building > Leading Multicultural Teams |
|
E-Folder - Leading Multicultural Teams
While managing a multicultural workforce while working overseas, I have seen the advantages multiculturalism According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product brings to an organization. However, these advantages do not always happen naturally. Our department was a ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ble to find ways to benefit from a multicultural group in order to maximize our performance. I believe that lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. a manager must create a strong sense of team, while respecting the differences of the individual cultures r here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe presented in the team. A multicultural work unit has the potential of bringing people together with a wide d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro range of experiences and ideas. This provides a team with the potential of discovering new ideas and approa ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ches to address business issues. The potential is for the team to find new approaches and ideas, combining easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi the different backgrounds in ways that generate better outcomes than more homogenous groups may be able to f nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nd. However, a manager must take time to develop the environment where these groups can work cohesively tog and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ether. First the leader (and team) must establish the values of the group. If there is not a value for dif ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ference or a reluctance to listen and try new ideas, those from a minority viewpoint or cultural reference m ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ay be reluctant to participate. Energy must also be taken to establish a sense of team. Since the group is dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod not homogenous it may be more difficult for a leader to establish a commonality among the members. I rememb cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin er a team building activity where we went to a baseball game our international team. While the Americans an tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen d Latins loved the opportunity, our French Morrocan partner participated but did not enjoy the event. Howev t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel er, at other times we went to soccer games, French cooking lessons, bowling, and a great variety of other ac ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ivities to give some members of the team time to share interests with other members. This helps to strength y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products en the team. Once the values, ground rules and sharing begins I believe that a multicultural team can gener . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ate much improved solutions for a group or a company. References: Alder, N.J. (1983). Cross cultura elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip l management: Issues to be faced. International Journal of Management and Organization. 13 (1-2), pp. 7-4 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Talking Change: Ten Tips To Resoving Conflict in the Workplace Connecting With Your Customers Through Your Brand Identity How To Out-Market The Big Guys
|